Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Sheng Gelieting

Product Specifications

CAS Number

1152810-23-5

Target

Others|||Proteasome

Related Pathways

Others|||Ubiquitination|||Proteases/Proteasome

Bioactivity

Sheng Gelieting (CGT-8012) is an inhibitor of the dipeptidyl peptidase-IV enzyme (DP-IV) with an IC50 value of 87 nM. It can be utilized for research into the dipeptidyl peptidase-IV enzyme, including studies on diabetes, particularly type II diabetes.

Smiles

C(F)(F)(F)C=1N2C(CN(C(C[C@@H](CC3=C(F)C=C(F)C(F)=C3)N)=O)CC2)=CN1

Molecular Formula

C17H16F6N4O

Molecular Weight

406.33

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Bt Cry2A antibody
70R-BR002 500 ug

Bt Cry2A antibody

Ask
View Details
Rabbit Anti-BOB 1/POU2AF1 Polyclonal Antibody
PAV5298 100 μL

Rabbit Anti-BOB 1/POU2AF1 Polyclonal Antibody

Ask
View Details
Pyrazole-3-carboxylic acid
HY-W002328-01 25 g

Pyrazole-3-carboxylic acid

Ask
View Details
Pyrazole-3-carboxylic acid
HY-W002328-02 100 g

Pyrazole-3-carboxylic acid

Ask
View Details
ELAVL3, NT (ELAVL3, HUC, PLE21, ELAV-like protein 3, Hu-antigen C, Paraneoplastic cerebellar degeneration-associated antigen, Paraneoplastic limbic encephalitis antigen 21) (FITC)
MBS6295196-01 0.2 mL

ELAVL3, NT (ELAVL3, HUC, PLE21, ELAV-like protein 3, Hu-antigen C, Paraneoplastic cerebellar degeneration-associated antigen, Paraneoplastic limbic encephalitis antigen 21) (FITC)

Ask
View Details
ELAVL3, NT (ELAVL3, HUC, PLE21, ELAV-like protein 3, Hu-antigen C, Paraneoplastic cerebellar degeneration-associated antigen, Paraneoplastic limbic encephalitis antigen 21) (FITC)
MBS6295196-02 5x 0.2 mL

ELAVL3, NT (ELAVL3, HUC, PLE21, ELAV-like protein 3, Hu-antigen C, Paraneoplastic cerebellar degeneration-associated antigen, Paraneoplastic limbic encephalitis antigen 21) (FITC)

Ask
View Details